The stock of Bone Biologics Corp (NASDAQ:BBLG) last traded at $0.49, down -7.71% from the previous session.
Data from the available sources indicates that Bone Biologics Corp (NASDAQ:BBLG) is covered by 1 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $7.50 and a low of $7.50, we find $7.50. Given the previous closing price of $0.53, this indicates a potential upside of 1315.09 percent. BBLG stock price is now -19.91% away from the 50-day moving average and -87.13% away from the 200-day moving average. The market capitalization of the company currently stands at $1.52M.
In total, 0 analysts have assigned it a hold rating, and 1 have given it a buy rating. Brokers who have rated the stock have averaged $7.50 as their price target over the next twelve months.
In other news, Walsh Deina H, Chief Financial Officer bought 8,000 shares of the company’s stock on Sep 13. The stock was bought for $5,120 at an average price of $0.64. Upon completion of the transaction, the Chief Financial Officer now directly owns 15,000 shares in the company, valued at $7350.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 11, Chief Executive Officer Frelick Jeff bought 9,500 shares of the business’s stock. A total of $6,530 was incurred on buying the stock at an average price of $0.69. This leaves the insider owning 17,204 shares of the company worth $8429.96. Insiders disposed of 500,137 shares of company stock worth roughly $0.25 million over the past 1 year. A total of 12.90% of the company’s stock is owned by insiders.
With an opening price of $0.5115 on Wednesday morning, Bone Biologics Corp (NASDAQ: BBLG) set off the trading day. During the past 12 months, Bone Biologics Corp has had a low of $0.47 and a high of $13.20. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 1.69, and a quick ratio of 1.69. The fifty day moving average price for BBLG is $0.6069 and a two-hundred day moving average price translates $3.7765 for the stock.
The latest earnings results from Bone Biologics Corp (NASDAQ: BBLG) was released for Sep, 2023.
